Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Prepaid Assets (2017 - 2025)

Historic Prepaid Assets for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $15.0 million.

  • Arcus Biosciences' Prepaid Assets fell 3181.82% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year decrease of 3181.82%. This contributed to the annual value of $18.0 million for FY2024, which is 4705.88% down from last year.
  • Latest data reveals that Arcus Biosciences reported Prepaid Assets of $15.0 million as of Q3 2025, which was down 3181.82% from $20.0 million recorded in Q2 2025.
  • Over the past 5 years, Arcus Biosciences' Prepaid Assets peaked at $34.0 million during Q4 2023, and registered a low of $8.7 million during Q1 2021.
  • Over the past 5 years, Arcus Biosciences' median Prepaid Assets value was $20.0 million (recorded in 2025), while the average stood at $21.5 million.
  • As far as peak fluctuations go, Arcus Biosciences' Prepaid Assets soared by 22900.75% in 2021, and later tumbled by 4705.88% in 2024.
  • Quarter analysis of 5 years shows Arcus Biosciences' Prepaid Assets stood at $18.0 million in 2021, then increased by 5.56% to $19.0 million in 2022, then surged by 78.95% to $34.0 million in 2023, then tumbled by 47.06% to $18.0 million in 2024, then fell by 16.67% to $15.0 million in 2025.
  • Its Prepaid Assets was $15.0 million in Q3 2025, compared to $20.0 million in Q2 2025 and $19.0 million in Q1 2025.